A New Weapon Against Hypertension
Recently approved medication lowers blood pressure, reducing risks of heart failure, stroke, heart attack, aneurysm, and kidney failure.
It’s been more than a decade since doctors received a new drug to help them battle hypertension (high blood pressure) in patients. During that time, the hypertension epidemic has grown to affect an estimated 25 percent of Americans—and it still remains uncontrolled in nearly 70 percent of those who have it. That’s why the recent approval of a new hypertension drug—aliskiren (Tekturna)—by the U.S. Food and Drug Administration (FDA) is of interest.